Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Spotlight
GLP-1s
Interviews
FDA
Strategy
Generics
Biosimilars
Value Added Medicines
Business
Deals
Earnings
Manufacturing
Policy & Regulation
Regulatory Landscape
Drug Pricing
IP & Litigation
Tools & Trackers
What's Next?
Who's Hired?
UK Pricing Tracker
Company Rankings
Podcasts
Conference Coverage
Partner Insights
Generics Bulletin Perspectives
Exploring market-shifting topics for the off-patent sector.
View
Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Perrigo Delivers ‘Remarkable Quarter’ As OTC Birth Control Waits In Wings
Opill Would Be The First OTC Daily Contraceptive Available In The US, If Approved
Aug 26 2022
•
By
Chloe Kent
Opill would be the first contraceptive licensed for OTC use in the US • Source: Shutterstock
More from Earnings
More from Business